{"transactions":[{"id":1137422,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T21:39:27.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from May 21, 2025; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-21","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001415889-25-014227","document":"form4-05222025_090523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925014227/form4-05222025_090523.xml","form_type":"4"}},{"id":1335863,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-12-11T21:45:16.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from October 23, 2024; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":117000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-12-09","underlying":"Class A Ordinary Shares","underlying_shares":117000},"source":{"system":"sec-edgar","filing":"0001415889-24-028977","document":"form4-12112024_041213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924028977/form4-12112024_041213.xml","form_type":"4"}},{"id":1503845,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares","published_at":"2024-05-23T12:53:36.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":80000,"price":6.2,"value":496000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $6.194848 to $6.199696 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-24-014179","document":"form4-05232024_120531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924014179/form4-05232024_120531.xml","form_type":"4"}},{"id":1669754,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":79405,"kind":"person","name":"Ploos van Amstel Arnout","position":1,"cik":"0001870330","reported_name":"Ploos van Amstel Arnout","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2024-01-26T16:32:02.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":48149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of options to purchase 48,149 Class A Ordinary Shares. The vesting for 48,149 shares began on November 9, 2023 and would vest over a period of three years, with each 1/3 on an annual basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of options to purchase 48,149 Class A Ordinary Shares. The vesting for 48,149 shares began on November 9, 2023 and would vest over a period of three years, with each 1/3 on an annual basis."}],"balance_after":48149,"derivative":{"exercise_price":3.98,"expiration_date":"2034-01-24","underlying":"Class A Ordinary Shares","underlying_shares":48149},"source":{"system":"sec-edgar","filing":"0001104659-24-007065","document":"tm244212-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924007065/tm244212-3_4seq1.xml","form_type":"4"}}]}